Recalls / Active ingredient / Esomeprazole Magnesium Dihydrate
Esomeprazole Magnesium Dihydrate
5 FDA drug recalls involving the active ingredient “Esomeprazole Magnesium Dihydrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2025-05-13 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx | Zydus Pharmaceuticals (USA) Inc |
| 2025-05-13 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx | Zydus Pharmaceuticals (USA) Inc |
| 2024-11-14 | Class III | Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufacture | Zydus Pharmaceuticals (USA) Inc |
| 2020-12-17 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension 40mg, packaged in unit dose packets, Rx only, Manuf | CIPLA |
| 2020-12-17 | Class II | Esomeprazole Magnesium for Delayed-Release Oral Suspension 20mg, packaged in unit dose packets, Rx only, Manuf | CIPLA |